These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8438432)

  • 1. Misoprostol in renal transplantation.
    Curtis LD; Anwar N; Briggs JD; Buckels JA; Jones M; Karim MS; Koffman G; McGregor E; Neild G; Riad HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):602. PubMed ID: 8438432
    [No Abstract]   [Full Text] [Related]  

  • 2. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple drug maintenance therapy in renal transplantation.
    Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A
    Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine immunosuppression in non-heart-beating cadaver donors.
    Asano H; Uchida K; Tominaga Y; Haba T; Sato K; Numano M; Orihara A; Yokoyama I; Takagi H
    Transplant Proc; 1992 Oct; 24(5):2042-3. PubMed ID: 1412965
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
    Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
    Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical usefulness of conventional fine needle aspiration cytology in kidney transplantation--influence of different immunosuppressive protocols.
    Almirall J; Sole M; Campistol JM; Muntane J; Bru C; Oppenheimer F; Andreu J; Revert L
    Transplant Proc; 1992 Feb; 24(1):71-2. PubMed ID: 1539350
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

  • 10. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic value of the postrejection treatment biopsy in renal transplantation.
    Mozes MF; Manaligod JR; Duke D; Pollak R; Maddux M; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1625-6. PubMed ID: 3274391
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytokine-release syndrome: differences between high and low doses of OKT3.
    Norman DJ; Kimball JA; Barry JM
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
    Friend PJ; Rebello P; Oliveira D; Manna V; Cobbold SP; Hale G; Jamieson NV; Jamieson I; Calne RY; Harris DT
    Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange in highly sensitized patients as induction therapy after renal transplantation.
    Reisaeter AV; Fauchald P; Leivestad T; Holdaas H; Hartmann A; Pfeffer P; Sødal G
    Transplant Proc; 1994 Jun; 26(3):1758. PubMed ID: 8030121
    [No Abstract]   [Full Text] [Related]  

  • 16. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma exchange vs cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts.
    Dikshit MP; Acharya VN; Trivedi HS; Almeida AF
    Transplant Proc; 1992 Oct; 24(5):1724. PubMed ID: 1412811
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor-specific transfusion in living-related renal transplants.
    Basri N; Nezamuddin N; Aman H; Banqash H; Sharwani N
    Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.